Navigation Links
Colorado Cancer Research Program Will Host Golf Event to 'Drive' the Message that Clinical Trials Play a Vital Role in the Quest to Find a Cure for Cancer
Date:4/28/2008

DENVER, April 28 /PRNewswire-USNewswire/ -- The Colorado Cancer Research Program (CCRP) invites golfers to participate in its second annual "Drive for a Cure" Golf Tournament on May 19 at the Valley Country Club, 14601 Country Club Drive, Aurora. The private club is one of Denver's premier golf courses and has been the home to major events such as the Colorado Women's Open. The club can also boast that two of its professional golfers have been inducted into the Colorado Hall of Fame.

By hosting this tournament, CCRP hopes to raise funds for clinical research and heighten public awareness of the role that clinical trials can play in helping those dealing with cancer today and those who may develop cancer in the future. Ultimately, a clinical trial may prove to be the vehicle that identifies a cure for the disease.

The benefits of clinical trials with CCRP are threefold: Firstly, they offer patients throughout Colorado access to the newest advancements in medical science, while continuing to offer the benefits of standard care. Secondly, they gauge the effectiveness of new approaches in treating a cancer, controlling the side effects of chemotherapy, or perhaps preventing a cancer altogether. Thirdly, they produce solid evidence regarding the safety and effectiveness of drugs that are still under evaluation. Proceeds from this year's golf tournament will directly benefit those affected by cancer in Colorado.

"Cancer research is crucial. I'm not sure there is anyone out there who has not been personally and deeply affected by cancer. I've lost two aunts and an uncle to the disease. My office manager lost her mother to it just last year and her father is battling it now," noted Nathan Mendel, owner of Mendel & Company Construction and a sponsor of the event. "This is an event and a cause that I am proud to sponsor."

The cost of the event is $185 per player. Golfers without a foursome will be placed into teams of four. Fees include green fees, cart fees, a boxed lunch and dinner.

Registration for this year's event begins at 11:30 am. This event has a best ball scramble format and will kick off with a shotgun start at 1:00 pm. In addition to first, second and third place prizes, there will be prizes for the best all-female team, closest to the pin, longest drive, and longest putt.

Additionally, there will be a "Hole in One" contest with the prize being offered by H.M. Brown & Associates. A silent auction will be held throughout the day, along with an awards dinner following the tournament. A complete schedule of events and a description of the silent auction items can be viewed at http://www.co-cancerresearch.org.

Mark Randall, former NBA player, Denver Nuggets Community Ambassador and current Chair of the "Drive for a Cure" Tournament 2008 will be playing in the tournament. "I support Colorado Cancer Research Program as they not only bring hope to countless individuals each and every day, but also to future generations," said Mark.

Major sponsors for the Golf Tournament include COPIC Financial Services, CSW Safety Services, Leopold Brothers, Longmont United Hospital, McDonald Automotive Group, Mendel & Company Construction, Metro Denver Anesthesia, Parker Adventist Hospital, Rocky Mountain Cancer Centers, Sherman & Howard, LLC, Celgene Pharmaceuticals and Coors Brewing Company.

"Last year we were able to raise $35,000 for CCRP and we expect to surpass that amount this year," said Nicholas DiBella, M.D. "Events like this are only possible through the participation and sponsorship of generous individuals and organizations."

Deadline for registration is May 12. To register, or for more information about the tournament, call Todd McKinley at (303) 777-2663 or visit http://www.co-cancerresearch.org.

If you are unable to play or volunteer, but would like to make a tax-deductable donation to CCRP, visit http://www.co-cancerresearch.org or mail a check to The Colorado Cancer Research Program, 2253 S. Oneida St., 3rd Floor, Suite B, Denver, CO 80224.

About Colorado Cancer Research Program

The Colorado Cancer Research Program (CCRP) is one of fifty non-profit Community Clinical Oncology Programs throughout the country that are sponsored by the National Cancer Institute. The CCRP's purpose is to ensure that cancer patients in Colorado, whether they are in the Denver metro area or in more remote locations, have easy access to the most cutting-edge cancer treatments. CCRP is a partnership of seventeen hospitals, over 100 community medical and radiation oncologists, surgeons, and other specialists throughout Colorado that are dedicated to bringing the most advanced care to those affected by cancer. For more information on the CCRP please visit http://www.co-cancerresearch.org.

Contact: Todd McKinley

(303) 777-2663 office

(303) 726-5426 cell

tmckinley@co-cancerresearch.org


'/>"/>
SOURCE Colorado Cancer Research Program
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Molecular Discoveries Shed Light on Liver Cancer -- Hepatocellular Carcinoma (HCC)
2. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
3. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
4. Report on 750 New Medicines in Development for Cancer Released in Baton Rouge
5. Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy With No Dose Limiting Toxicity in Metastatic Pancreatic Cancer
6. ACORN Presents Findings of Collaborative Metastatic Colorectal Cancer Research
7. Novel Xeloda(R) Dosing Schedule May Offer Well-Tolerated Alternative for Treatment of Advanced Breast Cancer
8. Aida Announces New Anti-Cancer Drug Under Development
9. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
10. Pharmacyclics Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer
11. Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles Snuffy Myers Announces Vitamin D Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... 2017  Market Research Future published a Half Cooked Research Report ... to reach USD 33.6 million during the period 2016 to 2022 ... ... Market has been examined as a swiftly growing market and expected ... for endoscopy device in various regions.  The increasing growth in endoscopy ...
(Date:1/17/2017)... Research and Markets has announced the addition of the ... their offering. ... The global fluoropolymer market in the healthcare industry to grow at ... Global Fluoropolymer Market in the Healthcare Industry 2016-2020, has been prepared ... The report covers the market landscape and its growth prospects over ...
(Date:1/17/2017)... , Jan. 17, 2017   Tocagen Inc ., a ... , Ph.D., executive vice president, research and pharmaceutical development at Tocagen, ... , to be held Jan. 17-20 in Miami ... follows: ... biotech oxymoron: exciting manufacturing for replicating viruses - what to do ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... ... Stalking Awareness Month (NSAM), now in its fourteenth year, when we turn the spotlight ... a very real danger to many in our community. We also take a look ... “Stalking: know it. Name it. Stop it.”—so reads the theme for this importance observance. ...
(Date:1/17/2017)... CA (PRWEB) , ... January 17, 2017 , ... ... concerned by the political/social/economic events, Dr. Carol Francis re-releases powerfully uplifting interview with ... magical moments that help everyone endure and pass through tough times, Dr. Bernie ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... century approach to infusing high speed technology into the fabric of an entire ... the advancement of healthcare and wellness in a yet-to-be-named, health focused campus. Leading ...
(Date:1/17/2017)... ... January 17, 2017 , ... Surgeons from New York’s fastest ... practitioners on the latest breakthroughs in the prevention, diagnosis and treatment of the ... to eye surgeon, Jeffrey Martin, MD, FACS, Chief Executive Officer of SightMD and ...
(Date:1/17/2017)... ... January 17, 2017 , ... SC&H Group, a leading audit, tax, ... in its IT Advisory Services practice . Rossi is the third technology consulting ... for strategic IT guidance grows, and the practice continues to expand.     , Bringing more ...
Breaking Medicine News(10 mins):